MICHAEL BENKOWITZ - 02 Nov 2021 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
President and COO
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
02 Nov 2021
Net transactions value
-$553,480
Form type
4
Filing time
03 Nov 2021, 16:37:45 UTC
Previous filing
29 Oct 2021
Next filing
05 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $215,320 +4,000 +179% $53.83 6,235 02 Nov 2021 Direct F1
transaction UTHR Common Stock Disposed to Issuer $768,800 -4,000 -64% $192.20 2,235 02 Nov 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -4,000 -17% $0.000000 20,000 02 Nov 2021 Common Stock 4,000 $53.83 Direct F1
holding UTHR Stock Options 63,000 02 Nov 2021 Common Stock 63,000 $146.03 Trust F2
holding UTHR Stock Options 26,250 02 Nov 2021 Common Stock 26,250 $146.03 Trust F2
holding UTHR Stock Options 42,940 02 Nov 2021 Common Stock 42,940 $146.03 Trust F2
holding UTHR Stock Options 69,750 02 Nov 2021 Common Stock 69,750 $146.03 Trust F2
holding UTHR Stock Options 64,148 02 Nov 2021 Common Stock 64,148 $111.00 Trust F3
holding UTHR Stock Options 85,531 02 Nov 2021 Common Stock 85,531 $111.00 Trust F4
holding UTHR Stock Options 187,500 02 Nov 2021 Common Stock 187,500 $135.42 Trust F4
holding UTHR Stock Options 187,500 02 Nov 2021 Common Stock 187,500 $117.76 Trust F4
holding UTHR Stock Options 39,200 02 Nov 2021 Common Stock 39,200 $120.26 Trust F4
holding UTHR Stock Options 52,500 02 Nov 2021 Common Stock 52,500 $102.11 Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 This stock option was transferred to a trust beneficially owned by the reporting person on October 23, 2021.
F3 On October 23, 2021 and November 2, 2021, 57,000 and 7,148 shares of this stock option grant, respectively, were transferred to trusts beneficially owned by the reporting person.
F4 This stock option was transferred to a trust beneficially owned by the reporting person on November 2, 2021.